Cargando…
Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
Autores principales: | Liu, Minglu, Hu, Tong, Gou, Wenfeng, Chang, Huajie, Li, Yanli, Li, Yiliang, Zuo, Daiying, Hou, Wenbin, Jiao, Shunchang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927636/ https://www.ncbi.nlm.nih.gov/pubmed/36798079 http://dx.doi.org/10.3389/fphar.2023.1140018 |
Ejemplares similares
-
Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
por: Liu, Minglu, et al.
Publicado: (2022) -
Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
por: Xue, Zhong, et al.
Publicado: (2023) -
Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis
por: Yang, Yingying, et al.
Publicado: (2021) -
Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations
por: Ling, Junjun, et al.
Publicado: (2022) -
Corrigendum: Pharmacological activity and clinical use of PDRN
por: Squadrito, Francesco, et al.
Publicado: (2022)